Visit mersi.com to make an appointment
Visit mersi.com to make an appointment
Synopsis
This is a phase IV clinical trial of a repository corticotropin injection (H.P. Acthar Gel) in order to treat non-infectious retinal vasculitis. Throughout the duration of this open label study, the safety and efficacy of the treatment will be evaluated. Participation is limited to patients 18 years of age or older with retinal vasculitis associated with a non-infectious ocular inflammatory disease. Patients will be followed for 24 weeks over the course of 6 office visits.
Synopsis
This is a phase IV clinical trial of a repository corticotropin injection (H.P. Acthar Gel) in order to treat non-infectious intermediate uveitis, posterior uveitis, or panuveitis (NIPPU). Throughout the duration of this open label study, the safety and efficacy of the treatment will be evaluated. Participation is limited to patients 18 years of age or older with active NIPPU. Patients will be followed for 44 weeks over the course of 13 visits.
This site complies with the HONcode standard for trustworthy health information: verify here.
